OIG device compliance guide?
This article was originally published in The Gray Sheet
Executive Summary
HHS Office of the Inspector General has no immediate plans to extend the pharmaceutical 1draft compliance guide's applicability to device companies, or to draft a separate guide for that industry, OIG says. At a recent FDLI event, lawyers debated the guide's relevance for device firms (2"The Gray Sheet" Nov. 11, 2002, p. 13)...